Canada · Delayed Price · Currency is CAD Lonza Group AG Company Description
Lonza Group AG is a leading multinational company in the life sciences sector, offering a broad range of products and services for pharmaceutical, biotech, and specialty chemicals markets.
With a strong focus on research and development, Lonza plays a critical role in the production and supply of advanced biologics and small molecules.
The company is renowned for its custom manufacturing services, enabling pharmaceutical companies to bring innovative therapies to market efficiently.
Lonza's operations span across multiple continents, providing an extensive portfolio that includes cell and gene therapy manufacturing, bioconjugates, and microbial technologies.
Its significance in the market is reinforced by its commitment to fostering technological advancements and sustainable solutions, thus positioning itself as a pivotal component of the global healthcare supply chain.
Headquartered in Basel, Switzerland, Lonza Group AG continues to expand its global footprint, contributing significantly to healthcare innovation and patient-centric solutions.
| Country | Canada |
Contact Details
No contact details available.
Stock Details
| Ticker Symbol | LON |
| Exchange | Cboe Canada |
| Reporting Currency | CAD |